The first draft of a human pangenomic reference, which includes 47 individuals selected to maximize biogeographic diversity, offers a path to more accurate and effective screening for disease. This broader and more complete view of genetic diversity could lead to new targets for cancer therapies.

©2023 American Association for Cancer Research
2023
American Association for Cancer Research
You do not currently have access to this content.